Gourgou-Bourgade, S <br/><br/>
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2015 
 - 873-879 p.  digital 
<br/><br/> Publication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdv106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--diagnosis<br/>Consensus<br/>Delphi Technique<br/>Disease Progression<br/>Disease-Free Survival<br/>Endpoint Determination--classification<br/>Female<br/>Humans<br/>Randomized Controlled Trials as Topic--classification<br/>Research Design--standards<br/>Terminology as Topic<br/>Time Factors<br/>Treatment Failure